General Information of Drug (ID: DMRQWRQ)

Drug Name
LY3316531
Indication
Disease Entry ICD 11 Status REF
Psoriasis vulgaris EA90 Phase 1 [1]
Cross-matching ID
TTD ID
D08FIB

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)